Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:ASND’

Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted......(read more)

How Did Ascendis Pharma A/S (ASND) Compare Against Hedge Fund Darlings in 2019?

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge......(read more)

Here’s What Hedge Funds Think About Ascendis Pharma A/S (ASND)

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook......(read more)

Here’s What Hedge Funds Think About Ascendis Pharma A/S (ASND)

How do we determine whether Ascendis Pharma A/S (NASDAQ:ASND) makes for a good investment at the moment? We analyze the sentiment of a select group of......(read more)

Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S (ASND)

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)

Wyndham Hotels & Resorts, Inc. (WH): 2019 Sohn Conference New York Recap

Sohn Conference is my favorite hedge fund event. I haven’t missed an event since 2013. This doesn’t mean that every stock pitched at the conference......(read more)

Did Hedge Funds Drop The Ball On Ascendis Pharma A/S (ASND) ?

Is Ascendis Pharma A/S (NASDAQ:ASND) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because......(read more)
GLENVIEW CAPITAL

Glenview Capital Management’s Stock Pitches At 2018 Sohn Conference

Glenview Capital Management is a New York City-based hedge fund, that was launched 18 years ago by Larry Robbins, who previously worked as a trader for......(read more)
Glen Kacher of Light Street Capital

Best Stock Pick From The 2018 Sohn Conference (Part II)

Read the beginning of this article here. Nathaniel August recommended a position in Peabody Energy (NYSE:BTU) which “is the largest and least expensive......(read more)

What Happened With Light Street’s Glen Kacher’s Best Idea at 2018 Sohn Conference?

It has been almost a year since the last annual Sohn Conference held in New York, and we thought it would be interesting to take a look at how some of......(read more)
Nathaniel August - Mangrove Partners

Mangrove Partners’ Nathaniel August’s Best Idea At 2018 Sohn Conference

Nathaniel August’s Mangrove Partners is known for outperforming the market very often; in the first three years since its launching (2010), the fund......(read more)
Alex Denner Sarissa Capital

Sarissa Capital Management Hires New President

Sarissa Capital Management was one of those rare activist hedge funds, which managed to beat the last year’s tough market environment, returning 15.......(read more)

Should You Buy Ascendis Pharma A/S (ASND)?

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......(read more)

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
Samuel Isaly - Orbimed Advisors

13D Filing: OrbiMed Advisors and Ascendis Pharma A/S (ASND)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Are Hedge Funds On To Something With Ascendis Pharma A/S (ASND) Bullishness?

Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Ascendis Pharma (ASND): OrbiMed Advisors Adds More Shares

Samuel Isaly just cannot get enough of Ascendis Pharma A/S (NASDAQ:ASND). According to an amended filing with the Securities and Exchange Commission,......(read more)
Samuel Isaly Orbimed Advisors

OrbiMed Advisors Buys Some More Ascendis Pharma (ASND) Shares

Samuel Isaly‘s OrbiMed Advisors has stepped up its interest in Ascendis Pharma A/S (NASDAQ:ASND) as reported in a recently-amended filing with......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Hedge Funds Aren’t Crazy About Ascendis Pharma A/S (ASND) Anymore

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than......(read more)
Barry Rosenstein JANA PARTNERS

Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company

You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......(read more)

Jacob Gottlieb Adds To Position In Ascendis Pharma A/S (ASND); Armistice Capital Increases Stake In Demand Media Inc (DMD)

Is it a good time to buy shares of Ascendis Pharma A/S (NASDAQ:ASND)? Jacob Gottlieb thinks so, since his fund, Visium Asset Management, has significantly......(read more)

Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company

Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working......(read more)